Workflow
Merit Medical(MMSI)
icon
Search documents
Merit Medical(MMSI) - 2022 Q1 - Earnings Call Presentation
2022-04-29 17:02
First Quarter 2022 Results 1 Merit Medical Investor Call April 27, 2022 Fred Lampropoulos Chairman and CEO Raul Parra CFO an | --- ...
Merit Medical(MMSI) - 2022 Q1 - Earnings Call Transcript
2022-04-28 03:07
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q1 2022 Earnings Conference Call April 27, 2022 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman and Chief Executive Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Raul Parra - Chief Financial Officer and Treasurer Joseph Wright - Chief Commercial Officer Conference Call Participants Jayson Bedford - Raymond James Larry Biegelsen - Wells Fargo Mike Matson - Needham Jim Sidoti - Sidoti Steven Lichtman - Oppenheimer William ...
Merit Medical(MMSI) - 2021 Q4 - Annual Report
2022-03-01 17:56
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2021 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from to . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or ...
Merit Medical(MMSI) - 2021 Q4 - Earnings Call Presentation
2022-02-28 15:28
| --- | --- | |-------------------------------------------------------------|-------| | | | | | | | 2021 Results and | | | Merit Medical Investor Call February 24, 2022 2022 Guidance | | | Fred Lampropoulos Chairman and CEO | | | Raul Parra CFO | | 1 2 CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This presentation and any accompanying management commentary include "forward-looking statements," as defined within applicable securities laws and regulations. All statements in this presentation, oth ...
Merit Medical(MMSI) - 2021 Q4 - Earnings Call Transcript
2022-02-26 13:55
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q4 2021 Earnings Conference Call February 24, 2022 5:00 PM ET Company Participants Fred Lampropoulos ??? Founder, Chairman and Chief Executive Officer Brian Lloyd ??? Chief Legal Officer and Corporate Secretary Raul Parra ??? Chief Financial Officer and Treasurer Conference Call Participants Larry Biegelsen ??? Wells Fargo Mike Matson ??? Needham Jayson Bedford ??? Raymond James Jim Sidoti ??? Sidoti & Company Bill Plovanic ??? Canaccord Steve Lichtman ??? Oppenheim ...
Merit Medical(MMSI) - 2021 Q3 - Quarterly Report
2021-11-05 20:53
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or ot ...
Merit Medical(MMSI) - 2021 Q3 - Earnings Call Transcript
2021-10-29 03:43
Merit Medical Systems, Inc (NASDAQ:MMSI) Q3 2021 Earnings Conference Call October 28, 2021 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman and Chief Executive Officer Brian Lloyd - Chief Legal Officer and Corporate Secretary Raul Parra - Chief Financial Officer and Treasure Conference Call Participants Mike Matson - Needham Jayson Bedford - Raymond James William Plovanic - Canaccord Steven Lichtman - Oppenheimer Jim Sidoti - Sidoti & Company Jason Bednar - Piper Sandler Operator G ...
Merit Medical(MMSI) - 2021 Q2 - Quarterly Report
2021-08-06 19:42
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 0-18592 (Address of principal executive offices, including zip code) Registrant's telephone number, including area code: (80 ...
Merit Medical(MMSI) - 2021 Q2 - Earnings Call Transcript
2021-07-31 14:02
Merit Medical Systems, Inc. (NASDAQ:MMSI) Q2 2021 Results Conference Call July 29, 2021 5:00 PM ET Company Participants Brian Lloyd - Chief Legal Officer & Corporate Secretary Fred Lampropoulos - President and Chief Executive Officer Raul Parra - Treasurer and Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James & Associates, Inc. Shagun Chadha - Wells Fargo Securities James Sidoti - Sidoti & Company Michael Matson - Needham & Company Steven Lichtman - Oppenheimer & Co Operat ...
Merit Medical(MMSI) - 2021 Q1 - Quarterly Report
2021-05-07 17:48
OR Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 0-18592 MERIT MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) Utah 87-0447695 (State or other ...